Faculty profile

Brian Buck

ResearcherMedicineUniversity of Alberta

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses may be missing. Find their university profile.

Brian Buck

Researcher

Medicine

Health Sciences

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
42 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

1,694

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Antiplatelet Post-Endovascular Thrombectomy Post-Thrombolysis Randomized Clinical Trial Secondary Stroke Prevention

Latest papers

Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
The Lancet · 2026
Association Between Ipsilateral Stroke and Nonstenotic (<50%) Carotid Disease: Secondary Analysis From the AcT Trial
Journal of the American Heart Association · 2026
Effect of time on reperfusion in acute ischemic stroke treated with thrombolysis within the 4.5-hour window: a secondary analysis of the AcT Trial
Journal of Stroke and Cerebrovascular Diseases · 2026

All 78 publications

Latest funding

Behavioural Intervention and Guided Stepping Training Early Post-Stroke (BIG STEPS)
CIHR · 2025 · Co-investigator
$787,950
Dual Antiplatelet Therapy in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (PRIME): A Randomized Pilot Study
CIHR · 2025 · Principal investigator
$730,576
Using Artificial Intelligence Based Solutions to Facilitate Clinical Trial Enrolment
SSHRC · 2021 · Co-investigator
$237,970

All 3 grants and awards

78 publications.

Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Broderick JP, Naidech AM, Elm JJ, Toyoda K, Dowlatshahi D, Demchuk AM, Khatri P, Steiner T, Bath PM, Audebert HJ

The Lancet202610 citations

DOI: 10.1016/s0140-6736(26)00097-8

Association Between Ipsilateral Stroke and Nonstenotic (<50%) Carotid Disease: Secondary Analysis From the AcT Trial

Ignacio KHD, Nagendra S, Bala F, Alhabli I, Kaveeta C, Tanaka K, Baguley E, Poulin T, Sjonnesen K, Horn M

Journal of the American Heart Association20261 citations

DOI: 10.1161/jaha.125.042821

Effect of time on reperfusion in acute ischemic stroke treated with thrombolysis within the 4.5-hour window: a secondary analysis of the AcT Trial

Ignacio KHD, Pensato U, Bala F, Buck B, Sajobi T, Catanese L, Tkach A, Swartz R, Demchuk A, Almekhlafi MA

Journal of Stroke and Cerebrovascular Diseases2026

DOI: 10.1016/j.jstrokecerebrovasdis.2026.108667

Tenecteplase versus alteplase in elderly stroke: a post hoc analysis of the AcT trial

Aslan T, AlShamrani M, Buck B, Singh N, Swartz RH, Sajobi T, Tkach A, Almekhlafi MA, Catanese L, Menon B

Stroke and Vascular Neurology2026

DOI: 10.1136/svn-2025-005030

Safety and Efficacy of Nerinetide at Year 1 in Participants Enrolled in ESCAPE‐NEXT: A Multicenter, Double‐Blind, Randomized Controlled Trial

Adams C, Heard K, Kohli Y, Vatanpour S, Berrouschot J, Buck B, Demchuk A, Dippel D, Dorn F, Field T

Journal of the American Heart Association2026

DOI: 10.1161/jaha.125.044080

Age-adjustment of the combined early ischemic change and collateral extent score for outcomes after endovascular therapy.

Tanaka K, Ganesh A, Zhang J, Najm M, Pensato U, Barakhanov K, Bala F, Kaveeta C, Almekhlafi M, Buck B

American Journal of Neuroradiology2026

DOI: 10.3174/ajnr.a9374

Cerebral Amyloid Angiopathy Imaging Markers, Radiological Boston Criteria, and Thrombolysis Outcomes in Ischemic Stroke

Marzoughi S, Alhabli I, Singh N, Bala F, Betzner W, Lam K, Buck B, Catanese L, Tkach A, Dowlatshahi D

Stroke2026

DOI: 10.1161/strokeaha.125.054654

Endovascular Acute Stroke Intervention–Tandem Occlusion (EASI-TOC) study: protocol and rationale

Mendes GN, Jacquin G, Iancu D, Roy D, Yu M, Bodson-Clermont P, Fahmi I, Ahmed SU, Almekhlafi M, Buck B

European Stroke Journal2026

DOI: 10.1093/esj/aakag036

Comparing Clinical Characteristics and Outcomes of Tenecteplase Versus Alteplase in Young Adult Patients With Stroke: A Secondary Analysis of the AcT Trial

Ignacio KHD, Bala F, Catanese L, Tkach A, Kate M, Buck B, Ademola A, Sajobi TT, Field TS, Pikula A

Stroke: Vascular and Interventional Neurology2026

DOI: 10.1161/svin.125.001974

Radiological thrombus characteristics and the effect of tenecteplase versus alteplase on outcomes in acute ischemic stroke.

Bala F, Ignacio K, Singh N, Alhabli I, Benali F, Khosravani H, Ganesh A, Tkach A, Catanese L, Dowlatshahi D

International Journal of Stroke2026

DOI: 10.1177/17474930261473813

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2025

Subject: Prospective PhD student: Antiplatelet Dear Professor Buck, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Dual Antiplatelet Therapy in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (PRIME): A Randomized Pilot Study" (2025), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Brian Buck

Research

Latest papers

Latest funding

Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Association Between Ipsilateral Stroke and Nonstenotic (<50%) Carotid Disease: Secondary Analysis From the AcT Trial

Effect of time on reperfusion in acute ischemic stroke treated with thrombolysis within the 4.5-hour window: a secondary analysis of the AcT Trial

Tenecteplase versus alteplase in elderly stroke: a post hoc analysis of the AcT trial

Safety and Efficacy of Nerinetide at Year 1 in Participants Enrolled in ESCAPE‐NEXT: A Multicenter, Double‐Blind, Randomized Controlled Trial

Age-adjustment of the combined early ischemic change and collateral extent score for outcomes after endovascular therapy.

Cerebral Amyloid Angiopathy Imaging Markers, Radiological Boston Criteria, and Thrombolysis Outcomes in Ischemic Stroke

Endovascular Acute Stroke Intervention–Tandem Occlusion (EASI-TOC) study: protocol and rationale

Comparing Clinical Characteristics and Outcomes of Tenecteplase Versus Alteplase in Young Adult Patients With Stroke: A Secondary Analysis of the AcT Trial

Radiological thrombus characteristics and the effect of tenecteplase versus alteplase on outcomes in acute ischemic stroke.

Behavioural Intervention and Guided Stepping Training Early Post-Stroke (BIG STEPS)

Dual Antiplatelet Therapy in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (PRIME): A Randomized Pilot Study

Using Artificial Intelligence Based Solutions to Facilitate Clinical Trial Enrolment

Frequent collaborators

Mahesh Kate

Dar Dowlatshahi

Nishita Singh

Luciana Catanese

Mohammed Almekhlafi

Kenneth Butcher

Aravind Ganesh

Houman Khosravani

Michel Shamy

Mayank Goyal

Houman Khosravani

Nishita Singh

Andrew Demchuk

Tolulope Sajobi

Ramana Appireddy

Aleksandra Pikula

Dariush Dowlatshahi

Mukul Sharma

Christian Beaulieu

Brian Buck

Richard Swartz

Bijoy Menon

Balraj Mann

Brian Buck

Bijoy Menon

Gustavo Saposnik

Richard Aviv

Mahesh Kate

Christian Stapf